About US
Contact us
-
Access announces agreement to develop oral formulation of proprietary injectable drugsAccess Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), announced today that it has entered into a pre-licensing feasibility agreement with a leading biotechnology company to develop an oral formulat2010/7/16
-
American Heart Association comments on FDA advisory committee's rosiglitazone recommendationsAfter two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on2010/7/16
-
BASF increases prices for beta-carotene and its derivatesLudwigshafen , Germany – July 14, 2010 – BASF globally increases the prices for beta-carotene and its derivatives canthaxanthin and apocarotenal by 12% with immediate effect or as existing commitmen2010/7/15
-
OraVerse MAA accepted for review in five key European countriesSanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agenc2010/7/15
-
FDA opens two-day hearing to examine safety of diabetes drug AvandiaThe Fiscal Times: "There will be more at stake than just one drug's future when the Food and Drug Administration opens a two-day hearing Tuesday on the safety of the diabetes drug Avandia. The 30-memb2010/7/15
-
SPET-085 is effective in blocking critical enzyme that leads to BPH: StudyA new study, published in the July issue of Advances in Therapy, revealed that a novel saw palmetto extract (SPE), SPET-085, is as effective as finasteride, the standard prescription drug therapy, i2010/7/14
-
Cognis exclusively licensed two new active ingredients from IMDSpecialty chemicals supplier Cognis and InterMed Discovery (IMD), a world class natural product lead-discovery company, are continuing their strategic cooperation: Cognis has now exclusively licensed2010/7/14
-
B. Braun Medical announces availability of large volume heparin infusion solutionsB.BraunMedicalInc.(B.Braun)announcedtodaytheavailabilityoflargevolumeheparininfusionsolutions. BasedonthenewUnitedStatesPharmacopeia(USP)standardsforheparinproductsreleasedbytheU.S.FoodandDrugAdminist2010/7/13
-
Brand-Nu Laboratories adds Chlophedianol Hydrochloride to API lineBrand-Nu Laboratories, a leading US-based high purity chemical manufacturer and distributor, has introduced Chlophedianol Hydrochloride, also known as Clofedanol Hydrochloride JP, to its product portf2010/7/13
-
FDA accepts Protalix's taliglucerase alfa NDA, assigns PDUFA action dateProtalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced today that the Company's New Drug Application (NDA) for taliglucerase alfa has been accepted for review by the U.S. Food and Drug Administrat2010/7/13